Health Care & Life Sciences » Pharmaceuticals | Nichi-iko Pharmaceutical Co. Ltd.

Nichi-iko Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
103,622
127,021
143,513
149,263
164,717
166,592
Cost of Goods Sold (COGS) incl. D&A
64,173
80,145
90,200
111,652
123,914
133,434
Gross Income
39,449
46,876
53,313
37,611
40,803
33,158
SG&A Expense
32,058
31,622
34,248
27,585
27,603
25,937
EBIT
7,383
15,271
19,086
-
13,200
7,221
Unusual Expense
4
36
543
2,927
3,304
589
Non Operating Income/Expense
41
138
2,932
954
44
594
Interest Expense
149
109
127
584
850
890
Pretax Income
7,055
9,488
15,359
5,963
9,067
8,903
Income Tax
2,467
2,896
4,328
1,166
997
2,039
Consolidated Net Income
4,588
6,592
11,031
4,796
8,069
6,864
Net Income
4,588
6,592
11,031
4,796
8,069
6,864
Net Income After Extraordinaries
4,588
6,592
11,031
4,796
8,069
6,864
Net Income Available to Common
4,588
6,592
11,031
4,796
8,070
6,864
EPS (Basic)
81.54
110.25
184.44
84.22
143.18
115.45
Basic Shares Outstanding
56
60
60
57
56
59
EPS (Diluted)
81.46
110.13
184.01
84.08
142.92
114.03
Diluted Shares Outstanding
56
60
60
57
56
60
EBITDA
13,406
20,265
24,200
17,091
22,179
16,987
Other Operating Expense
8
17
21
-
-
-
Non-Operating Interest Income
20
33
102
95
30
11
Equity in Affiliates (Pretax)
236
229
85
309
51
1,377

About Nichi-iko Pharmaceutical Co.

View Profile
Address
1-6-21 Sogawa
Toyama Toyama 930
Japan
Employees -
Website http://www.nichiiko.co.jp
Updated 07/08/2019
Nichi-Iko Pharmaceutical Co., Ltd. develops, manufactures, and markets generic pharmaceutical products. Its products are classified into Prescriptive and General Over-the-Counter (OTC) drugs. These products are used for the treatment of circulatory, digestive, respiratory, central and peripheral nervous systems problems.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.